Skip to main content
Premium Trial:

Request an Annual Quote

Fujitsu Biosciences Licenses BioMedCache Software to NeurAxon

NEW YORK, Feb. 22 (GenomeWeb News) - Fujitsu America's Biosciences group said today that it has licensed its BioMedCache automated docking and molecular modeling software to Canadian drug maker NeurAxon.


Under the terms of the agreement, NeurAxon will use the software's ActiveSite module to design small-molecule inhibitors of protein targets, Fujitsu said.


Financial terms of the deal were not disclosed.